Is FGF-23 an early indicator of atherosclerosis and cardiac dysfunction in patients with gestational diabetes?

OBJECTIVE: Fibroblast growth factor 23 (FGF-23) is a phosphorus-regulating hormone and plays a role in the pathogenesis of myocardial hypertrophy. The aim of this study was to evaluate the association of FGF-23 levels with echocardiographic parameters and insulin resistance (IR) in patients with ges...

Descripción completa

Detalles Bibliográficos
Autores principales: Tuzun, Dilek, Oguz, Ayten, Aydin, Muhammet Naci, Kurutas, Ergul Belge, Ercan, Onder, Sahin, Murat, Ünsal, Velid, Ceren, Imran, Akçay, Ahmet, Gul, Kamile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118658/
https://www.ncbi.nlm.nih.gov/pubmed/30462803
http://dx.doi.org/10.20945/2359-3997000000070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118658/
https://www.ncbi.nlm.nih.gov/pubmed/30462803
http://dx.doi.org/10.20945/2359-3997000000070

Ejemplares similares